scholarly journals Mortality Selection in a Genetic Sample and Implications for Association Studies

2016 ◽  
Author(s):  
Benjamin W. Domingue ◽  
Daniel W. Belsky ◽  
Amal Harrati ◽  
Dalton Conley ◽  
David Weir ◽  
...  

AbstractMortality selection is a general concern in the social and health sciences. Recently, existing health and social science cohorts have begun to collect genomic data. Causes of selection into a genomic dataset can influence results from genomic analyses. Selective non-participation, which is specific to a particular study and its participants, has received attention in the literature. But mortality selection—the very general phenomenon that genomic data collected at a particular age represents selective participation by only the subset of birth cohort members who have survived to the time of data collection—has been largely ignored. Here we test the hypothesis that such mortality selection may significantly alter estimates in polygenetic association studies of both health and non-health traits. We demonstrate mortality selection into genome-wide SNP data collection at older ages using the U.S.-based Health and Retirement Study (HRS). We then model the selection process. Finally, we test whether mortality selection alters estimates from genetic association studies. We find evidence for mortality selection. Healthier and more socioeconomically advantaged individuals are more likely to survive to be eligible to participate in the genetic sample of the HRS. Mortality selection leads to modest drift in estimating time-varying genetic effects, a drift that is enhanced when estimates are produced from data that has additional mortality selection. There is no general solution for correcting for mortality selection in a birth cohort prior to entry into a longitudinal study. We illustrate how genetic association studies using HRS data can adjust for mortality selection from study entry to time of genetic data collection by including probability weights that account for mortality selection. Mortality selection should be investigated more broadly in genetically-informed samples from other cohort studies.


2007 ◽  
Vol 16 (20) ◽  
pp. 2494-2505 ◽  
Author(s):  
Yasuhito Nannya ◽  
Kenjiro Taura ◽  
Mineo Kurokawa ◽  
Shigeru Chiba ◽  
Seishi Ogawa


2017 ◽  
Vol 28 (7) ◽  
pp. 1927-1941
Author(s):  
Jiyuan Hu ◽  
Wei Zhang ◽  
Xinmin Li ◽  
Dongdong Pan ◽  
Qizhai Li

In the past decade, genome-wide association studies have identified thousands of susceptible variants associated with complex human diseases and traits. Conducting follow-up genetic association studies has become a standard approach to validate the findings of genome-wide association studies. One problem of high interest in genetic association studies is to accurately estimate the strength of the association, which is often quantified by odds ratios in case-control studies. However, estimating the association directly by follow-up studies is inefficient since this approach ignores information from the genome-wide association studies. In this article, an estimator called GFcom, which integrates information from genome-wide association studies and follow-up studies, is proposed. The estimator includes both the point estimate and corresponding confidence interval. GFcom is more efficient than competing estimators regarding MSE and the length of confidence intervals. The superiority of GFcom is particularly evident when the genome-wide association study suffers from severe selection bias. Comprehensive simulation studies and applications to three real follow-up studies demonstrate the performance of the proposed estimator. An R package, “GFcom”, implementing our method is publicly available at https://github.com/JiyuanHu/GFcom .



2018 ◽  
Author(s):  
Matthew P. Conomos ◽  
Alex P. Reiner ◽  
Mary Sara McPeek ◽  
Timothy A. Thornton

AbstractLinear mixed models (LMMs) have become the standard approach for genetic association testing in the presence of sample structure. However, the performance of LMMs has primarily been evaluated in relatively homogeneous populations of European ancestry, despite many of the recent genetic association studies including samples from worldwide populations with diverse ancestries. In this paper, we demonstrate that existing LMM methods can have systematic miscalibration of association test statistics genome-wide in samples with heterogenous ancestry, resulting in both increased type-I error rates and a loss of power. Furthermore, we show that this miscalibration arises due to varying allele frequency differences across the genome among populations. To overcome this problem, we developed LMM-OPS, an LMM approach which orthogonally partitions diverse genetic structure into two components: distant population structure and recent genetic relatedness. In simulation studies with real and simulated genotype data, we demonstrate that LMM-OPS is appropriately calibrated in the presence of ancestry heterogeneity and outperforms existing LMM approaches, including EMMAX, GCTA, and GEMMA. We conduct a GWAS of white blood cell (WBC) count in an admixed sample of 3,551 Hispanic/Latino American women from the Women’s Health Initiative SNP Health Association Resource where LMM-OPS detects genome-wide significant associations with corresponding p-values that are one or more orders of magnitude smaller than those from competing LMM methods. We also identify a genome-wide significant association with regulatory variant rs2814778 in the DARC gene on chromosome 1, which generalizes to Hispanic/Latino Americans a previous association with reduced WBC count identified in African Americans.



2010 ◽  
Vol 19 (3) ◽  
pp. 347-352 ◽  
Author(s):  
Jeroen R Huyghe ◽  
Erik Fransen ◽  
Samuli Hannula ◽  
Lut Van Laer ◽  
Els Van Eyken ◽  
...  




2020 ◽  
Vol 21 (2) ◽  
pp. 125-140
Author(s):  
Márcia Ferreira ◽  
Margarida Freitas-Silva ◽  
Joana Assis ◽  
Ricardo Pinto ◽  
José P Nunes ◽  
...  

Despite the clinical benefits of aspirin, the interindividual variation in response to this antiplatelet drug is considerable. The manifestation of aspirin resistance (AR) is frequently observed, although this complex process remains poorly understood. While AR etiology is likely to be multifactorial, genetic factors appear to be preponderant. According to several genetic association studies, both genome-wide and candidate gene studies, numerous SNPs in cyclooxygenase, thromboxane and platelet receptors-related genes have been identified as capable of negatively affecting aspirin action. Thus, it is essential to understand the clinical relevance of AR-related SNPs as potential predictive and prognostic biomarkers as they may be essential to defining the AR phenotype.



Sign in / Sign up

Export Citation Format

Share Document